“…Breast and prostate carcinomas (Gonzalez-Reyes et al, 2010;Gonzalez-Reyes et al, 2011) TLR3, 4, 7, and 9 Esophageal squamous cell carcinoma (Sheyhidin et al, 2011) TLR4 Colon carcinoma, human head and neck squamous cell carcinoma, melanoma cell lines, NB-1 neuroblastoma, lung carcinoma, pancreatic ductal adenocarcinoma, colorectal carcinoma, adrenocortical carcinoma, ovarian cancer cell lines, bladder cancer cells (Hassan et al, 2006;Molteni et al, 2006;Doan et al, 2009;Qian et al, 2009;Szajnik et al, 2009;Szczepanski et al, 2009;Kanczkowski et al, 2010;Tang et al, 2010;Zhang et al, 2010;Xu et al, 2011) TLR4 and 9 Lung carcinoma (Zhang et al, 2009b) TLR4, 5, and 9 Gastric carcinoma (Schmausser et al, 2005) TLR5 Cervical tumor cells, breast cancer cells, colon carcinoma, gastric cancer cells (Kim et al, 2008;Rhee et al, 2008;Cai et al, 2011;Song et al, 2011) TLR7 (Huang et al, 2005;Yang et al, 2010) of several human cancers, including neuroblastoma, breast adenocarcinoma, and cervical, hepatocellular, papillary thyroid, nasopharyngeal and lung carcinomas. TLR4 expression in human lung cancer cells was demonstrated (He et al, 2007b).…”